On-Q-ity

About:

On-Q-ity develops non-invasive diagnostic monitoring tools for use in the treatment of individual cancer patients.

Website: http://www.on-q-ity.com

Top Investors: Bessemer Venture Partners, Atlas Venture, Mohr Davidow Ventures, Northgate Capital, Physic Ventures

Description:

On-Q-ity is an innovative diagnostic company that is focused on providing physicians with the tools they need to make the best decision when treating individual cancer patients. There platform will enable better decision-making across multiple cancers: improving the quality of life for patients and ultimately increasing survival. Products currently in development are based on two core technologies: 1) DNA repair biomarkers that predict treatment response and 2) Microfluidic chip technology that enables capture, enumeration and characterization of circulating tumor cells (CTCs) in the bloodstream.

Total Funding Amount:

$31M

Headquarters Location:

Waltham, Massachusetts, United States

Founded Date:

2004-01-01

Contact Email:

info(AT)on-q-ity.com

Founders:

Mara Aspinall

Number of Employees:

11-50

Last Funding Date:

2012-02-28

IPO Status:

Private

Industries:

© 2025 bioDAO.ai